1. Home
  2. WEAV vs PHAT Comparison

WEAV vs PHAT Comparison

Compare WEAV & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEAV
  • PHAT
  • Stock Information
  • Founded
  • WEAV 2011
  • PHAT 2018
  • Country
  • WEAV United States
  • PHAT United States
  • Employees
  • WEAV N/A
  • PHAT N/A
  • Industry
  • WEAV EDP Services
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEAV Technology
  • PHAT Health Care
  • Exchange
  • WEAV Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • WEAV 613.5M
  • PHAT 727.5M
  • IPO Year
  • WEAV 2021
  • PHAT 2019
  • Fundamental
  • Price
  • WEAV $8.79
  • PHAT $8.91
  • Analyst Decision
  • WEAV Strong Buy
  • PHAT Strong Buy
  • Analyst Count
  • WEAV 5
  • PHAT 5
  • Target Price
  • WEAV $16.10
  • PHAT $16.40
  • AVG Volume (30 Days)
  • WEAV 982.1K
  • PHAT 5.0M
  • Earning Date
  • WEAV 07-30-2025
  • PHAT 08-07-2025
  • Dividend Yield
  • WEAV N/A
  • PHAT N/A
  • EPS Growth
  • WEAV N/A
  • PHAT N/A
  • EPS
  • WEAV N/A
  • PHAT N/A
  • Revenue
  • WEAV $212,950,000.00
  • PHAT $81,859,000.00
  • Revenue This Year
  • WEAV $18.69
  • PHAT $195.45
  • Revenue Next Year
  • WEAV $15.71
  • PHAT $106.76
  • P/E Ratio
  • WEAV N/A
  • PHAT N/A
  • Revenue Growth
  • WEAV 19.58
  • PHAT 3055.70
  • 52 Week Low
  • WEAV $7.91
  • PHAT $2.21
  • 52 Week High
  • WEAV $17.63
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • WEAV 37.41
  • PHAT 53.97
  • Support Level
  • WEAV $7.98
  • PHAT $8.72
  • Resistance Level
  • WEAV $8.68
  • PHAT $10.13
  • Average True Range (ATR)
  • WEAV 0.32
  • PHAT 0.81
  • MACD
  • WEAV 0.01
  • PHAT -0.33
  • Stochastic Oscillator
  • WEAV 28.16
  • PHAT 3.96

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: